MoneyWorks4Me

Marksans Pharma informs about buyback of equity shares

25 Oct 2022 Evaluate
Marksans Pharma has informed that it submitted the daily report pursuant to Regulation 18 of the SEBI Buyback Regulations regarding the Equity Shares bought back on October 25, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..